Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background: Polycyclic aromatic hydrocarbons (PAHs) have toxic potential, especially as carcinogens, neurotoxins, and endocrine disruptors. The objective of this study is to know the impact of exposure to PAHs on the reproductive health of male workers who operate in solar thermal plants. Methods: Case–control study. A total of 61 men were included: 32 workers exposed to PAH at a solar thermal plant and 29 unexposed people. Seminal quality was studied both at the cellular level (quantity and quality of sperm) and at the biochemical level (magnitudes of oxidative stress in seminal plasma). Results: In exposure to PAHs, a significantly higher seminal leukocyte infiltration was observed, as well as lower activity in seminal plasma of superoxide dismutase (SOD) and a reduced glutathione/oxidised glutathione (GSH/GSSG) ratio. The oxidative stress parameters of seminal plasma did not show a relationship with sperm cellularity, neither in those exposed nor in those not exposed to PAH. Conclusion: One year of exposure to PAH in a solar thermal plant does not have a negative impact on the sperm cellularity of the worker, either quantitatively (sperm count) or qualitatively (motility, vitality, morphology, or cellular DNA fragmentation). However, PAH exposure is associated with lower antioxidant capacity and higher leukocyte infiltration in seminal plasma.

Details

Title
One-Year Impact of Occupational Exposure to Polycyclic Aromatic Hydrocarbons on Sperm Quality
Author
Peña-García, Mª Victoria 1 ; Moyano-Gallego, Mª José 1 ; Gómez-Melero, Sara 2   VIAFID ORCID Logo  ; Molero-Payán, Rafael 2   VIAFID ORCID Logo  ; Rodríguez-Cantalejo, Fernando 1 ; Caballero-Villarraso, Javier 3   VIAFID ORCID Logo 

 Clinical Analyses Service, Reina Sofía University Hospital, 14004 Córdoba, Spain; [email protected] (M.V.P.-G.); [email protected] (M.J.M.-G.); [email protected] (F.R.-C.) 
 Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain; [email protected] (S.G.-M.); [email protected] (R.M.-P.) 
 Clinical Analyses Service, Reina Sofía University Hospital, 14004 Córdoba, Spain; [email protected] (M.V.P.-G.); [email protected] (M.J.M.-G.); [email protected] (F.R.-C.); Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain; [email protected] (S.G.-M.); [email protected] (R.M.-P.); Department of Biochemistry and Molecular Biology, Universidad of Córdoba, 14071 Córdoba, Spain 
First page
1181
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20763921
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3120512150
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.